Combination therapy in hormone-refractory prostate cancer

被引：0
|
作者：
Daniel P. Petrylak
机构：
来源：
Current Oncology Reports | 2001年 / 3卷 / 5期
关键词：
Prostate Cancer; Hydrocortisone; Docetaxel; Mitoxantrone; Estramustine;
D O I：
10.1007/s11912-001-0033-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 453
相关论文
共 50 条
  • [41] The role of endothelin in hormone-refractory prostate cancer
    Zonnenberg, BA
    Voest, EE
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 9 - 14
  • [42] Pyrazoloacridine for the treatment of hormone-refractory prostate cancer
    Small, EJ
    Fippin, LJ
    Whisenant, SP
    CANCER INVESTIGATION, 1998, 16 (07) : 456 - 461
  • [43] Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer
    Kaku, H
    Saika, T
    Tsushima, T
    Nagai, A
    Yokoyama, T
    Abarzua, F
    Ebara, S
    Manabe, D
    Nasu, Y
    Kumon, H
    ACTA MEDICA OKAYAMA, 2006, 60 (01) : 43 - 49
  • [44] Docetaxel and exisulind in hormone-refractory prostate cancer
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 56 - 61
  • [45] Future therapies in hormone-refractory prostate cancer
    Smith, MR
    Nelson, JB
    UROLOGY, 2005, 65 (5A) : 9 - 16
  • [46] Chemotherapy for the treatment of hormone-refractory prostate cancer
    Petrylak, DP
    EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 15 - 23
  • [47] The continuing challenge of hormone-refractory prostate cancer
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2006, 4 (04) : 238 - 239
  • [48] Hormone-refractory prostate cancer responding to bevacizumab
    Iacobelli, Stefano
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (08) : 754 - 754
  • [49] Chemotherapy for patients with hormone-refractory prostate cancer
    Joly, F
    Tannock, IF
    ANNALS OF ONCOLOGY, 2004, 15 (11) : 1582 - 1584
  • [50] Hormone-refractory prostate cancer responding to capecitabine
    El-Rayes, BF
    Black, CA
    Ensley, JF
    UROLOGY, 2003, 61 (02)
12345